Advanced Medical Solutions Group Share News (AMS)

Tuesday broker round-up UPDATE

Advanced Medical Solutions: Panmure Gordon downgrades from buy to hold with a target price of 102p. Antofagasta: Canaccord Genuity cuts target price from 1110p to 1035p, while staying with its buy recommendation. ASOS: Panmure Gordon increases target price from 5950p to 6126p, while downgrading fr

Advanced Medical Solutions on track to hit forecasts

Advanced Medical Solutions (AMS), the AIM-listed medical technology firm, said it expects revenue and profit for 2013 to be in line with market expectations. The company, which develops and manufactures would-care and wound-closure products, said that the good progress made in the first half has co

Wednesday broker round-up UPDATE

Advanced Medical Solutions: N+1 Singer shifts target price from 84p to 90p and upgrades from sell to hold. Afren: Nomura lowers target price from 180p to 170p and retains a neutral rating. Aveva: Panmure Gordon raises target price from 2174p to 2374p and keeps a hold recommendation. Barclays: Soc

DIRECTOR DEALINGS: Advance Medical Solutions Grants Exec Options

BBA Aviation CEO sells 85,000 shares

BBA Aviation Chief Executive, Simon Pryce, on Friday traded in 85,000 shares, reducing his stake in the FTSE 100 group to 989,720. Pryce sold the shares at 321.26p each, pocketing £273,070. The transaction was made less than a week after the company said talks had ended with Dubai Aerospace Enter

DIRECTOR DEALINGS: Advanced Medical Solutions Executive Exercises Options, Sells Shares

Advanced Medical Solutions Profits, Revenues Rise

Advanced Medical Solutions H1 growth in line with expectations

Wound treatment developer Advanced Medical Solutions grew profits by a third in the first half, with both branded and white label products selling well. Group revenue climbed 11% to £27.4m, aided by currency effects, as increased margins helped pre-tax profit and diluted earnings both jump 33% to £

Wednesday broker round-up UPDATE

Advanced Medical Solutions: Panmure Gordon moves target price from 90p to 102p and reiterates a buy recommendation. Amara Mining: Numis shifts target price from 40p to 45p retaining its buy recommendation. Anite: Numis cuts target price from 155p to 128p and downgrades to hold. Ashmore Group: Ban

Own brand products underpin revenue growth at Advanced Medical Solutions

AIM-listed Advanced Medical Solutions reported that group revenue rose 53 per cent to 52.6m pounds in the year ended December 31st, supported by strong performance in its own brand business, Branded Direct. Within the Branded Direct business, ActivHeal brand achieved a 29% increase in revenues, Liq

Wednesday broker round-up UPDATE

Advanced Medical Solutions: Investec takes target price from 68p to 74p and maintains a buy recommendation. Aggreko: Citigroup reduces target price from 2550p to 2100p, while keeping a buy rating. Ashtead Group: Citigroup raises target price from 590p to 660p leaving its buy recommendation unalter

Tuesday broker round-up UPDATE

Admiral Group: Investec takes target price from 570p to 582p, but still recommends selling. Advanced Medical Solutions: Investec upgrades from hold to buy with a target price of 68p. African Barrick Gold: Canaccord Genuity reduces target price from 360p to 305p keeping a hold rating. Anglo Americ

Advanced Medical Solutions reports poor US sales

Advanced Medical Solutions has revealed its annual profits will be at the 'lower end' of market expectations. The news was unveiled Thursday in the UK-based global medical technology company's trading update which reported lower-than-expected sales of their LiquidBand product in the US market. Th